Geneva, July 7 -- International Clinical Trials Registry received information related to the study (KCT0012165) titled 'A Human Application Study to Evaluate the Efficacy and Safety of Undenatured Type II Collagen for the Improvement of Joint Pain' on June 24.
Study Type: Interventional Study
Study Design:
Primary Purpose : Other(Study for the efficacy and safety), Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT
Primary Sponsor: Songwon University
Condition:
Not Applicable
Intervention:
Dietary Supplement : Test group: 1 capsule once daily, 130 mg/day (containing 40 mg/day of undenatured type II collagen), 12-week intake
Control group: 1 capsule once daily, 130 m...